101 session 1

When two treatments having different dosage forms are compared to one another.

• Double-blinded

• Double-Zuksh

• Single-blinded

• Double-dummy

The main question of the study.

• Secondary outcome

• Primary outcome

• Composite outcome

• Endpoint

Study program done with double-dummy blinding type

• SUSTAIN

• BOOST

• EVOLVE

• CONCLUD

Event-driven trial

• BEGIN

• DEVOTE

• BOOST

• PIONEER

It is an overview of all patients involved in the study.

• Eligibility criteria

• Inclusion criteria

• Baseline characteristics

• Inclusion and baseline characteristics